NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Pylum Biosciences, Inc.

Pylum Biosciences, Inc.

Private
San Carlos, CaliforniaHealthcare & Life Scienceshttps://pylumbio.com/

Last Round

Seed

Mar 5, 2020

Total Funding Raised

$962,000

Company Overview

Pylum Biosciences, Inc. is a biotechnology company that develops precision anti-bacterial technology and bactericidal protein complexes targeting specific bacterial pathogens.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

precision antibacterialsprotein engineeringbactericidal proteinsantibiotic resistancephage therapynarrow-spectrum antibioticsdrug discoverybiotechnologyinfectious diseasemicrobiome therapeuticsbiodefensepreclinical developmentdrug-resistant pathogenssuperbug treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pylum Biosciences, Inc. Comparables

Compare Pylum Biosciences, Inc. with similar companies based on industry and business-model similarity.

Pylum Biosciences, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eligo Bioscience
82%
Locus Biosciences
81%
BiomX Inc.
74%

Pylum Biosciences, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 5, 2020
GrantJan 28, 2019

Pylum Biosciences, Inc. Investors

Notable investors and investment history

Pylum Biosciences, Inc. investors
InvestorRounds
National Institute of Allergy and Infectious DiseasesGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 8, 2024

    Grew 300% QoQ from 1 to 4 employees.

  • Mar 5, 2020

    $990K raised in Seed round.

Pylum Biosciences, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pylum Biosciences, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pylum Biosciences, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Carlos, California
Employee Range4
Year Founded2016
Last FundingMar 5, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.